Who Manages Restarting ADHD Medications: PCP vs Psychiatry
As a PCP, you should be managing the restart of ADHD medications for most patients, not just refills—this is explicitly within your scope according to current guidelines 1. However, specific clinical scenarios warrant psychiatry referral.
Your Role as PCP in ADHD Management
The 2019 AAP guidelines are clear: primary care clinicians should initiate evaluation, diagnose, titrate medications, and provide ongoing management of ADHD as a chronic condition 1. This isn't limited to simple refills. The guideline specifically states that PCPs should:
- Initiate ADHD evaluations for patients presenting with behavioral/academic problems
- Make the diagnosis using DSM-5 criteria
- Start and titrate medications to achieve maximum benefit with tolerable side effects
- Manage ADHD as a chronic condition following the medical home model 1
The rationale is practical: ADHD's high prevalence combined with limited mental health resources requires PCCs to play a central role in diagnosis and treatment 1. Research confirms that while PCPs report less confidence than psychiatrists in diagnosing and treating ADHD (8% vs 27-28% "extremely confident"), they can safely manage these patients 2, 3.
When to Refer to Psychiatry
Refer to psychiatry when:
- Complex comorbidities exist that you're not trained/experienced in managing—specifically severe mood disorders, severe anxiety disorders, or substance use disorders requiring specialized treatment 1
- "Complex ADHD" is present: age <4 years, moderate-to-severe functional impairment, diagnostic uncertainty, or inadequate response to treatment 4
- You lack confidence in diagnosing comorbid conditions that alter ADHD treatment 1
The guideline explicitly states: "It is generally the role of the primary care pediatrician to manage mild-to-moderate ADHD, anxiety, depression, and substance use" 1. Only severe presentations or those outside your training warrant referral.
Restarting Medications: Practical Approach
When restarting a patient on ADHD medication:
Obtain previous medication history from patient, family, and prior records—understand what worked, what didn't, and why it was stopped 5
Screen for current comorbidities that might have emerged: depression, anxiety, substance use (especially in adolescents/adults), learning disabilities 1
Assess for contraindications that developed during the medication gap
Restart at previous effective dose if recently discontinued, or restart at lower dose and retitrate if significant time has passed
Monitor closely using parent/teacher rating scales and follow-up within 7-30 days for dose adjustment 1
Common Pitfalls
Don't reflexively refer to psychiatry just because you're uncomfortable—this contributes to treatment gaps and poor outcomes. ADHD discontinuation increases risk of motor vehicle crashes, criminality, depression, and other injuries 1
Don't assume you need psychiatry for comorbid conditions—mild-to-moderate anxiety and depression are within your scope 1
Don't restart without monitoring plan—ADHD requires chronic disease management, not episodic care 1
Urban PCPs face greater feasibility challenges than suburban providers in ADHD assessment, so consider practice-based resources for school communication 6
Bottom Line
You should be restarting ADHD medications in your practice for uncomplicated cases and mild-to-moderate comorbidities 1. Reserve psychiatry referrals for severe comorbid psychiatric conditions, complex ADHD, or situations genuinely outside your training. The evidence shows PCPs can safely manage ADHD pharmacotherapy, including restarts, when following guideline-based care 7.